Episode Summary: 

In this episode of BetterTech Podcast on Digital Transformation in Biopharma, Jocelyn Houle interviews Nishtha Jain, Head of Innovation and Digital Technology at Takeda to discuss AI’s transformative role in the biopharma industry. They explore how AI streamlines drug discovery, improves clinical trials, and enhances patient outcomes. The conversation of Digital Transformation in Biopharma, covers challenges like data quality, strategic AI adoption, and navigating regulatory landscapes. Jain also highlights ethical considerations, including data security and human oversight, and initiatives promoting health equity in clinical trials. The episode concludes with key insights for innovators, focusing on impactful solutions, collaboration, and regulatory compliance.

Show Notes:

1. Nishtha delved into how AI accelerates drug discovery and clinical trials, significantly reducing development time and enhancing patient recruitment.
2.. Addressing data quality, ethical concerns, and regulatory compliance remains vital for AI adoption.
3. Strategic frameworks like DUST and leadership commitment drive successful AI integration.
4. Transparency, collaboration, and human oversight are crucial for building trust and addressing healthcare disparities.
5. Nishtha explored how AI is transforming personalized medicine, fostering innovation, and shaping the future of biopharma.

This episode is hosted by Jocelyn Byrne Houle, Host, BetterTech